Skip to content
Search

Latest Stories

RPS celebrates 'South Asian Heritage Month' with pharmacists

The Royal Pharmaceutical Society (RPS) is celebrating South Asian Heritage Month July 18- August 17 with south Asian pharmacy professionals. 

The event highlights the history and identity of British South Asians communities to better understand how Britain became the diverse country it is today. It aims to transform how people connect with South Asian culture and identity through the celebration of arts, culture, and heritage, history, and education.


Inaugurated in 2020, South Asian Heritage Month is about reclaiming the history and identity of British South Asians. People need to be able to tell their own stories, and this is an opportunity to show what it means to be south Asian in the 21st century, as well as look to the past to see how Britain became the diverse country it is today," said RPS. 

It added: "South Asian influences can be found everywhere in Britain, from our food and clothes to our music and even our words. The streets of our towns and cities are rich with the colours, sights, and sounds of proud south Asian identity. Its culture permeates all parts of British life and adds to the diversity of the nation." 

The live-stream events take place at 1 pm and will also be available afterwards on-demand. 

28 July South Asian Female Pharmacy Leaders

4 August Considering Intersectionality within the South Asian Community

11 August Collaborating across the profession

Book onto evening webinar Celebrating South Asian Month in Pharmacy 7pm-8.30pm on 12th August for a family-friendly quiz night celebrating the south Asian Community in pharmacy. 

Participants can also learn more about the diversity in cultures and backgrounds across the south Asian communities and hear the lived experiences of people who have been working in the pharmacy.

"We’re working closely with Pharmacy Technicians of Colour, NHS England, Boots and the Association of Pharmacy Technicians to celebrate the month. If you’re interested in getting involved and want to share your story contact Amandeep Doll, head of professional belonging at RPS on IandD@rpharms.com," the RPS said. 

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less